We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Maureen Beresini - Principal Scientific Manager II, Biochemical & Cellular Pharmacology

Maureen Beresini

Principal Scientific Manager II, Biochemical & Cellular Pharmacology

"After many years at Genentech, I am still faced with a wealth of new opportunities for learning and collaboration."
Years at Genentech
Publications at Genentech
Awards & Honors

I joined Genentech in 1992 because of its reputation for outstanding science. When I arrived, I was most impressed by the strong collaborative relationships that quickly developed among my colleagues. I feel fortunate that my position has allowed me to connect my past experiences in protein chemistry as a graduate student, cell biology as a postdoctoral fellow, and assay development gained in industry. My many years at Genentech have continually provided me with opportunities to learn and grow scientifically while contributing to the discovery of therapeutics. It has been extremely rewarding to be a part of the growth and development of the small molecule organization from one that makes selective molecules to one that makes drugs that help patients. My recent work in large molecule discovery has allowed me to appreciate the role of process optimization in advancing therapeutic targets.

Featured Publication

Development of a Potent, Specific CDK8 Kinase Inhibitor Which Phenocopies CDK8/19 Knockout Cells.

ACS Med Chem Lett. 2016 Jan 6;7(3):223-8.

Koehler MF, Bergeron P, Blackwood EM, Bowman K, Clark KR, Firestein R, Kiefer JR, Maskos K, McCleland ML, Orren L, Salphati L, Schmidt S, Schneider EV, Wu J, Beresini MH.